Nanoproteomics enabling personalized nanomedicine

Advanced Drug Delivery Reviews

Volumn 64, Issue 13, 2012, Pages 1522-1531

  Nicolini, Claudio ^a,b,c   Bragazzi, Nicola ^a   Pechkova, Eugenia ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Nanoworld Institute Fondazione ELBA Nicolini Bergamo   (Italy)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

APA; Leader Genes; MS; NAPPA; QMC_D; QMC_F

Indexed keywords

APA; MS; NAPPA; QMC_D; QMC_F;

GENES; MASS SPECTROMETRY; MEDICAL NANOTECHNOLOGY; NUCLEIC ACIDS; QUARTZ;

PROTEINS;

ALUMINUM OXIDE;

CELL FREE SYSTEM; FLUORESCENCE; GENE IDENTIFICATION; GRAVIMETRY; MASS SPECTROMETRY; NANOMEDICINE; NANOPROTEOMICS; NUCLEIC ACID PROGRAMMABLE PROTEIN ARRAY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUARTZ MICRO CIRCUIT NANOGRAVIMETRY; REVIEW; RNA INTERFERENCE;

ALUMINUM OXIDE; HUMANS; INDIVIDUALIZED MEDICINE; MASS SPECTROMETRY; NANOMEDICINE; NANOTECHNOLOGY; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 84867659106     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.06.015     Document Type: Review

References (85)

1. Jain K.K. Role of nanobiotechnology in the development of personalized medicine. Nanomedicine 2009, 4:249-252.
2. Jain K.K. Integration of biotechnologies for the development of personalized medicine. Pharmaceutical Biotechnology 2010, John Wiley & Sons. 2nd ed. O. Kayser, H. Warzecha (Eds.).
3. Jain K.K. Handbook of Nanomedicine 2008, Humana/Springer, Totowa, NJ.
4. Nicolini C. Nanogenomics in medicine. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:59-76.
5. Jain K.K. Using proteomics to identify targets and leads. Trends Biotechnol. 2002, 20:319-320.
6. Boja E., Hiltke T., Rivers R., Kinsinger C., Rahbar A., Mesri M., Rodriguez H. Evolution of clinical proteomics and its role in medicine. J. Proteome Res. 2011, 10(1):66-84.
7. Faratian D., Goltsov A., Lebedeva G., Sorokin A., Moodie S., Mullen P., Kay C., Um I.H., Langdon S., Goryanin I., Harrison D.J. Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res. Aug 15 2009, 69(16):6713-6720.
8. Hanash, Taguchi Application of proteomics to cancer early detection. Cancer J. Nov-Dec 2011, 17(6):423-428.
9. Allen M., Spiegel A.M., Hawkins M. 'Personalized medicine' to identify genetic risks for type 2 diabetes and focus prevention: can it fulfill its promise?. Health Aff. January 2012, 31:143-149.
10. Marko-Varga G., Ogiwara A., Nishimura T., Kawamura T., Fujii K., Kawakami T., Kyono Y., Tu H.K., Anyoji H., Kanazawa M., Akimoto S., Hirano T., Tsuboi M., Nishio K., Hada S., Jiang H., Fukuoka M., Nakata K., Nishiwaki Y., Kunito H., Peers I.S., Harbron C.G., South M.C., Higenbottam T., Nyberg F., Kudoh S., Kato H. Personalized medicine and proteomics: lessons from non-small cell lung cancer. J. Proteome Res. Aug 2007, 6(8):2925-2935.
11. Park J., Lee D.S., Christakis N.A., Barabási A.-L. The impact of cellular networks on disease comorbidity. Mol. Syst. Biol. 2009, 5(262):1-7.
12. Blair R.H., Trichler D.L., Gaille D.P. Mathematical and Statistical Modeling in Cancer Systems Biology. Front Physiol. 2012, 3:227.
13. Goh K.-I., Cusick M.E., Valle D., Childs B., Vidal M., Barabási A.-L. The human disease network. Proc. Natl. Acad. Sci. 2007, 104(21):8685.
14. Vidal M., Cusick M.E., Barabasi A.-L. Interactome networks and human disease. Cell 2011, 144:986-995.
15. Barabási A.L. Network medicine from obesity to the "diseasome". N. Engl. J. Med. 2007, 357:404-407.
16. Perkins D., Verma M., Park K.J. Advances of genomic science and systems biology in renal transplantation: a review. Semin. Immunopathol. Mar 2011, 33(2):211-218.
17. Pankow J.S., Dunn D.M., Hunt S.C., Leppert M.F., Miller M.B., Rao D.C., Heiss G., Oberman A., Lalouel J.M., Weiss R.B. Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) study. Am. J. Hypertens. 2005, 18:672-678.
18. Lee D.-S., Park J., Kay K.A., Christakis N.A., Oltvai Z.N., Barabási A.-L. The implications of human metabolic network topology for disease comorbidity. Proc. Natl. Acad. Sci. 2008, 105:9880-9885.
19. Neale M.C., Kendler K.S. Models of comorbidity for multifactorial disorders. Am. J. Hum. Genet. 1995, 57(4):935-953.
20. Pearson M.A., Fabbro D. Targeting protein kinases in cancer therapy: a success?. Expert Rev. Anticancer Ther. 2004, 4(6):1113-1124.
21. V. Janjić, N. Pržulj, The Core Diseasome. Mol. Biosyst. 2012 Jul 23 [Electronic publication ahead of print].
22. R.M. Piro, Network medicine: linking disorders. Hum. Genet. 2012 Jul 24 [Electronic publication ahead of print].
23. Loscalzo J., Kohane I., Barabási A.-L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol. 2007, 3(124):1-11.
24. Loscalzo J. Association studies in an era of too much information - clinical analysis of newbiomarker and genetic data. Circulation 2007, 116(17):1866-1870.
25. Barabási A.-L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 2011, 12:56-68.
26. T. Hwang, G. Atluri, M. Xie, S. Dey, C. Hong, V. Kumar, R. Kuang, Co-clustering phenome-genome for phenotype classification and disease gene discovery. Nucleic Acids Res. 2012 Jun 26 [Electronic publication ahead of print].
27. Loscalzo J., Barabási A.-L. Systems biology and the future of medicine. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3:619-627.
28. Faratian D., Clyde R.G., Crawford J.W., Harrison D.J. Nat. Rev. Clin. Oncol. Aug 2009, 6(8):455-464. (Systems pathology-taking molecular pathology into a new dimension).
29. Yildirim M.A., Goh K.-L., Cusick M.E., Barabási A.-L., Vidal M. Drug-target network. Nat. Biotechnol. 2007, 25(10):1119-1126.
30. Dai J.L., Chan D. Decoding the folding patterns of serum proteins: an alternative strategy for cancer biomarker validation. Clin. Proteomics 2010, 6:53-55.
31. Hughes A.J., Lin R.K.C., Peeh D.M., Herr A.E. Microfluidic integration for automated targeted proteomic assays. Proc. Natl. Acad. Sci. U. S. A. Apr 17 2012, 109(16):5972-5977.
32. Gold L., Walker J.J., Wilcox S.K., Williams S. Advances in human proteomics at high scale with the SOMAscan proteomics platform. New Biotechnol. June 15 2012, 29(5):543-549.
33. Sivozhelezov V., Giacomelli L., Tripathi S., Nicolini C. Gene expression in the cell cycle of human T lymphocytes: I. Predicted gene and protein networks. J. Cell. Biochem. 2006, 97:1137-1150.
34. Nicolini C., Spera R., Stura E., Fiordoro S., Giacomelli L. Gene expression in the cell cycle of human T lymphocytes: II. Experimental determination by DNASER technology. J. Cell. Biochem. 2006, 97:1151-1159.
35. Nicolini C. Nanogenomics for medicine. Nanomedicine 2006, 1:147-151.
36. LaBaer J., Ramachandran N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol. 2005, 9:14-19.
37. Ramachandran N., Raphael J.V., Hainsworth E., Demirkan G., Fuentes M.G., Rolfs A., Hu Y., LaBaer J. Next-generation high-density self-assembling functional protein arrays. J. Nat. Methods 2008, 5(6):535-538.
38. Nagl, Schaeferling M., Wolfbeis O.S. Fluorescence analysis in microarray technology. Microchim. Acta 2005, 151:1.
39. Nicolini C., LaBaer J. Functional Proteomics and Nanotechnology-based Microarrays (vol. 2). Pan Stanford Series on Nanobiotechnology 2010, vol. 2:1-306. Published 1rst July 2010 by Pan Stanford Publishing, London-New York-Singapore.
40. Garibaldi S., Brunelli C., Bavastrello V., Ghigliotti G., Nicolini C. Carbon nanotube biocompatibility with cardiac muscle cells. Nanotechnology 2006, 17:391-397.
41. Pechkova E., Nicolini C. Protein nanocrystallography: a new approach to structural proteomics. Trends Biotechnol. 2004, 22:117-122.
42. Pechkova E., Riekel C. Synchroton radiation and structural proteomics. Pan Stanford Series on Nanobiotechnology 2012, vol. 3:1-430. Published 11th November 2011 by Pan Stanford Publishing, Singapore.
43. Nicolini C., Peckova E. Nanoproteomics in nanomedicine. Nanomedicine 2010, 5:677-682.
44. Nicolini C., Pechkova E. An overview of nanotechnology-based functional proteomics from cancer and cell cycle progression. Anticancer Res. 2010, 30(6):2073-2080.
45. Ramachandran N., Hainsworth E., Bhullar B., Eisenstein S., Rosen B., Lau A.Y., Walter J.C., LaBaer J. Self-assembling protein microarrays. Science 2004, 305:86-90.
46. Ramachandran N., Larson D.N., Stark P.R.H., Hainsworth E., LaBaer J. Emerging tools for real-time label-free detection of interactions on functional protein microarrays. FEBS J. 2005, 272:5412-5425.
47. Bragazzi N.L., Sivozhelezov V., Nicolini C. Leader Gene: a fast data-mining tool for molecular genomics. J. Proteomics Bioinform. 2011, 4:83-86.
48. Racapé M., Bragazzi N.L., Sivozhelezov V., Danger R., Pechkova E., Soulillou J.P., Brouard S., Nicolini C. SMILE silencing and PMA activation in HeLa cells. J. Cell. Biochem. 2012, 113(6):1820-1832.
49. Braud C., Baeten D., Giral M., Pallier A., Ashton-Chess J., Braudeau C., Chevalier C., Lebars A., Leger J., Moreau A., Pechkova E., Nicolini C., Soulillou J.P., Brouard S. Immunosuppressive drug-free operational immune tollerance in human kidney transplant recipient: I. Blood gene expression statistical analysis. J. Cell. Biochem. 2008, 103:1681-1692.
50. Sivozhelezov V., Braud C., Giacomelli L., Pechkova E., Giral M., Soulillou J.P., Brouard S., Nicolini C. Immunosuppressive drug-free operational immune tollerance in human kidney transplant recipient: II Non-statistical gene microarray analysis. J. Cell. Biochem. 2008, 103:1693-1706.
51. Mangan S., Zaslaver A., Alon U. The coherent feed-forward loop serves as a sign-sensitive delay element in transcription networks. J. Mol. Biol. 2003, 334:197-204.
52. Brazhnik P., de la Fuente A., Mendes P. Gene networks: how to put the function in genomics. Trends Biotechnol. 2002, 20(11):467-472.
53. Sivozhelezov V., Spera R., Giacomelli L., Hainsworth E., LaBaer J., Bragazzi N.L., Nicolini C. Bioinformatics and fluorescence DNAser for NAPPA studies on cell transformation and cell cycle?. Pan Stanford Series on Nanobiotechnology 2010, vol. 2:31-59. Published 1st July 2010 by Pan Stanford Publishing, London-New York-Singapore. C. Nicolini, J. LaBaer (Eds.).
54. Spera R., Labaer J., Nicolini C. Maldi TOF detection of NAPPA. J. Mass Spectrom. 2011, 46(9):960-965.
55. Spera R., Nicolini C. Nappa microarrays and mass spectrometry: new trends and challenges. Essentials in Nanoscience Booklet Series January 15 2008, Taylor & Francis Group, LLC, NanoscienceWorks.org.
56. Zhu W., Smith J.W., Huang C.M. Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010, 840518.
57. Ho Y., Gruhler A., Heilbut A., Bader G., Moore L., Adams S., Millar A., Taylor P., Bennett K., Boutilier K., Yang L., Wolting C., Donaldson I., Schandorff S., Shewnarane J., Vo M., Taggart J., Goudreault M., Muskat B., Alfarano C., Dewar D., Lin Z., Michalickova K., Willems A.R., Sassi H., Nielsen P.A., Rasmussen K.J., Andersen J.R., Johansen L.E., Hansen L.H., Jespersen H., Podtelejnikov A., Nielsen E., Crawford J., Poulsen V., Sørensen B.D., Matthiesen J., Hendrickson R.C., Gleeson F., Pawson T., Moran M.F., Durocher D., Mann M., Hogue C.W.V., Figeys D., Tyers M. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 2002, 415:180-183.
58. Anderson K., Sibani S., Wallstrom G., Mendoza E., Hainsworth E., Montor W., Mong J., Park I., Lokko N., Logvinenko T., Ramachandran N., Engstrom P., Labaer J. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J. Proteome Res. 2011, 10(1):85-96.
59. Pechkova E., Chong S., Tripathi S., Nicolini C. Cell free expression and APA for NAPPA and protein crystallography. Pan Stanford Series on Nanobiotechnology 2010, vol. 2 (Chapter 7):121-147. Published 1st July 2010 by Pan Stanford Publishing, London-New York-Singapore. C. Nicolini, J. LaBaer (Eds.).
60. Rodahl M., Kasemo B. A simple setup to simultaneously measure the resonant frequency and the absolute dissipation factor of a quartz crystal microbalance. Rev. Sci. Instrum. 1996, 67:3238-3241.
61. Bradshaw L. Understanding piezoelectric quartz crystals. RF time and frequency 2000, 8:50-58.
62. Höök F., Vörös J., Rodahl M., Kurrat R., Böni P., Ramsden J.J., Textor M., Spencer N.D., Tengvall P., Gold J., Kasemo B. A comparative study of protein adsorption on titanium oxide surfaces using in situ ellipsometry, optical waveguide lightmode spectroscopy, and quartz crystal microbalance/dissipation. Colloids Surf. B Biointerfaces 2002, 24:155-170.
63. Matarraz S., Gonzalez-Gonzalez M., Jara M., Orfao A., Fuentes M. New technologies in cancer protein microarrays for biomarker discovery. Clin. Transl. Oncol. 2011, 13:156-161.
64. Wang S., Shan X., Patel U., Lu J., Tao N. Label free imaging, detection and mass measurement of single viruses by surface plasmon resonance. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(37):16028-16032.
65. Feley K., Shan X., Tao N. Surface impedance imaging technique. Anal. Chem. 2008, 80:5146-5151.
66. Adami M., Sallam S., Eggenhoffner R., Sartore M., Hainsworth E., LaBaer J., Nicolini C. Label-free NAPPA via nanogravimetry. Pan Stanford Series on Nanobiotechnology 2010, vol. 2 (Chapter 4):95-108. Published 1st July 2010 by Pan Stanford Publishing, London-New York-Singapore. C. Nicolini, J. LaBaer (Eds.).
67. [67] Terencio Bezzerra, R. Spera, M. Sartore, C. Nicolini, A new NAPPA-based nanogravimetric biosensor, In preparation.
68. C. Nicolini, T. Bezerra, E. Stura, R. Spera, C. Larosa, J. LaBaer, E. Pechkova. Atomic force microscopy and anodic porous allumina of nucleic acid programmable protein arrays. Recent Patents Biotechnol. (in press).
69. Sartore M., Eggenhoffner R., Bezerra Correia Terencio T., Stura E., Hainsworth, LaBaer J., Nicolini C. Label-free detection of NAPPA via atomic force microscopy. Pan Stanford Series on Nanobiotechnology 2010, vol. 2 (Chapter 6):109-120. Published 1st July 2010 by Pan Stanford Publishing, London -New York -Singapore. C. Nicolini, J. LaBaer (Eds.).
70. Stura E., Larosa C., Bezerra Correia Terencio T., Hainsworth E., Ramachandran N., LaBaer J., Nicolini C. Label-free NAPPA: anodic porous alumina. Pan Stanford Series on Nanobiotechnology 2010, vol. 2 (Chapter 5):95-108. Published 1st July 2010 by Pan Stanford Publishing, London-New York-Singapore. C. Nicolini, J. LaBaer (Eds.).
71. Grasso V., Lambertini V., Ghisellini P., Valerio F., Stura E., Perlo P., Nicolini C. Nanostructuring of a porous alumina matrix for a biomolecular microarray. Nanotechnology 2006, 17:795-798.
72. Stura E., Bruzzese D., Valerio F., Grasso F., Perlo P., Nicolini C. Anodic porous alumina as mechanical stability enhancer for LDL-cholesterol sensitive electrodes. Biosens. Bioelectron. 2007, 23:655-660.
73. Collings F.B., Vaidya V.S. Novel technologies for the discovery and quantitation of biomarkers of toxicity. Toxicology 2008, 245:167-174.
74. Madu C.O., Lu Y. Novel diagnostic biomarkers for prostate cancer. J. Cancer. 2010, 1:150-177.
75. Wang J. Carbon-nanotube based electrochemical biosensors: a review. Electroanalysis 2005, 17:1.
76. Umehara S., Karhanek M., Davis R.W., Pourmand N. Label-free biosensing with functionalized nanopipette probes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4611-4616.
77. Gold D.V., Modrak D.E., Ying Z., Cardillo T.M., Sharkey R.M., Goldenberg D.M. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J. Clin. Oncol. 2006, 24:252-258.
78. Hueber W., Robinson W. Proteomic biomarkers for autoimmune disease. Proteomics 2006, 6:4100-4105.
79. Chikkaveeraiah B.V., Mani V., Patel V., Gutkind J.S., Rusling J.F. Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens. Bioelectron. 2011, 26:4477-4483.
80. Uetz P., Giot L., Cagney G., Mansfield T., Judson R., Knight J., Lockshon D., Narayan V., Srinivasan M., Pochart P., Qureshi-Emili A., Li Y., Godwin B., Conover D., Kalbfleisch T., Vijayadamodar G., Yang M.J., Johnston M., Fields S., Rothberg J.M. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 403:623-627.
81. Walhout A., Sordella R., Lu X., Hartley J., Temple G., Brasch M., Thierry-Mieg N., Vidal M. Protein interaction mapping in C. elegans using proteins involved in vulval development. Science 2000, 287:116-122.
82. Zhu H., Bilgin M., Bangham R., Hall D., Casamayor A., Bertone P., Lan N., Jansen R., Bidlingmaier S., Houfek T., Mitchell T., Miller P., Dean R.A., Gerstein M., Snyder M. Global analysis of protein activities using proteome chips. Science 2001, 293:2101-2105.
83. Ray S., Reddy P.J., Choudhary S., Raghu D., Srivastava S. Emerging nanoproteomics approaches for disease biomarker detection: a current perspective. J. Proteomics Nov 18 2011, 74(12):2660-2681.
84. Dasilva N., Díez P., Matarraz S., González-González M., Paradinas S., Orfao A., Fuentes M. Biomarker discovery by novel sensors based on nanoproteomics approaches. Sensors 2012, 12:2284-2308.
85. Gonzalez-Gonzalez M., Jara-Acevedo R., Matarraz S., Jara-Acevedo M., Paradinas S., Sayagües J.M., Orfao A., Fuentes M. Nanotechniques in proteomics: protein microarrays and novel detection platforms. Eur. J. Pharm. Sci. 2012, 45(4):499-506.